Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1387 (LINC01387) is a long intergenic non-coding RNA (lincRNA), part of a class of RNA transcripts longer than 200 nucleotides that do not overlap with protein-coding genes and lack protein-coding potential[1][3]. LincRNAs, including LINC01387, generally regulate gene expression through mechanisms such as chromatin remodeling, transcriptional regulation, and RNA stabilization, with diverse roles in tissue-specific functions[1][3]. Although some lincRNAs have been functionally linked to human disease and gene regulatory networks, there is currently no direct evidence in the literature supporting LINC01387 as a characterized therapeutic target, nor its involvement in specific disease mechanisms. It is annotated as "putative uncharacterized protein" in some databases, but prevailing scientific agreement indicates it is non-coding, and there is no validated protein product[1][3]. LINC01387 is not a receptor, enzyme, transporter, or classic drug target, but may have regulatory roles in the human genome typical of its RNA class.
Not applicable or uncharacterized
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1387 (LINC01387).